Evidence map›Paper›PMID 41502422›Full record

ArticleRedox biochemistry and chemistry2025

Deacetylation of SOD3 by sirtuins restores furin cleavage.

Emily C Mitchem, Peter S Harris, Cole R Michel, Courtney D McGinnis, Shashikant Ray, Krishna M G Mallela, James R Roede, Steen V Petersen, Eva S Nozik, Kristofer S Fritz

Abstract read
In one paragraph

Article in Redox biochemistry and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emily C MitchemSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.ORCID 0009-0007-1534-3849
Peter S HarrisSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.ORCID 0000-0003-0324-0862
Cole R MichelSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.ORCID 0000-0002-9058-7495
Courtney D McGinnisSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Shashikant RayDepartment of Biotechnology, Mahatma Gandhi Central University, Motihari, Bihar, India, 845401.ORCID 0000-0001-8838-398X
Krishna M G MallelaSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
James R RoedeSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.ORCID 0000-0002-8425-6366
Steen V PetersenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Eva S NozikCardiovascular Pulmonary Research Laboratories and Pediatric Critical Care, Department of Pediatrics, The University of Colorado Anschutz Medical Center, Aurora, CO, 80045, USA.ORCID 0000-0002-7229-5528
Kristofer S FritzSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.ORCID 0000-0002-1499-6174

Funding

Xenobiotic Biotransformation in Down SyndromeR01ES027593 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI James R Roede · 2017 to 2026
$5.1M
Alcohol Metabolism Disrupts Hepatic Thiol Redox Signaling and ControlR01AA030024 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI Kristofer S Fritz · 2023 to 2026
$1.8M
Fusion Lumos Orbitrap System for Quantitative Proteomics and Metabolomics ApplicationsS10OD028538 · OD · UNIVERSITY OF COLORADO DENVER · PI REISDORPH, NICHOLE A · 2021 to 2021
$1.3M
NIAAA NIH HHS R01 AA030024NIEHS NIH HHS R01 ES027593NIH HHS S10 OD028538
6 · The paper itself

Abstract

Accumulation of superoxide radicals leads to disrupted redox signaling and oxidative damage. The primary extracellular scavenger of superoxide is extracellular superoxide dismutase (SOD3), a crucial enzyme in maintaining antioxidant status and proper immune function. SOD3 distribution to the extracellular matrix is determined by the presence of a C-terminal heparin-binding domain (HBD). This region can be removed through intracellular proteolytic processing by furin. Cleavage of the HBD has been shown to be modulated by post-translational cysteine redox status, regulating the secretion of SOD3. Interestingly, other members of the SOD family, SOD1 and SOD2, are known to be inhibited by lysine acetylation, a metabolically linked post-translational modification (PTM) that can alter protein structure, function, and localization. Yet, no reports describe the effect of acetylation on SOD3. Here, immunoblotting and mass spectrometry (MS) were used to quantify the global and site-specific acetylation of recombinant human SOD3. Interestingly, a predicted and targeted parallel reaction monitoring (PRM) MS-based approach was necessary to identify lysine acetylation within the C-terminal HBD of SOD3. Acetylation was found to prevent furin cleavage with no impact on SOD3 activity. Our results also reveal that SOD3 is robustly deacetylated by NAD

Indexed as

EC-SODFurinLysine acetylationOxidative stressSirtuinSuperoxide dismutase 3

Identifiers

PMID41502422
PMCPMC12774472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.